A drawback in suppressing the mTOR signaling in tumor cells, is the removal of the negative feedback loop mediated by p70S6 kinase, thus leading to the reactivation of PKB/Akt and ERK1/2 pathways downstream of growth factor receptors (i.e., insulin and IGF-1 receptors). Here, AKT1 is linked to neoplasm.